Results 121 to 130 of about 301,386 (199)

The spatial immune landscape predicts outcome and reveals the central role of tumor-associated macrophages in inflammatory breast cancer biology. [PDF]

Breast Cancer Res
Van Berckelaer C, Van Laere S, Vermeulen C, Kockx M, Waumans Y, Marien K, Rypens C, Missal N, Berditchevski F, Bertucci F, Vermeulen P, Dirix L, Colpaert C, Devi GR, Van Dam P.   +14 more
europepmc   +1 more source

Adjuvant and neoadjuvant therapy with lapatinib in ErbB2-overexpressing breast cancer [PDF]

, 2008
Möbus, Volker, Minckwitz, Gunter von, Nitz, Ulrike, Janni, Wolfgang   +3 more
core   +1 more source

Clinical Significance and Prognostic Value of TLR4 and AGER in Inflammatory Breast Cancer. [PDF]

Cancers (Basel)
Paiva LDAS, Teles ACF, Souza JDS, Oliveira PRA, Alves BES, Coelho MTB, Cajado AG, Maia IFVC, Silva PGB, Cavalcante DIM, Cunha MDPSS, Arruda LM, Lima-Júnior RCP, Rogatto SR, Wong DVT.   +14 more
europepmc   +1 more source

Exome sequencing reveals new insights into the germline landscape of inflammatory breast cancer among Tunisian patients. [PDF]

J Transl Med
Boujemaa M, Hamdi Y, Guidara S, Souissi A, Bouaziz H, Mejri N, Aloulou S, Mahjoub N, Chaabane K, Hakim H, Boussen H, Dhiab TB, Kamoun S, Ayadi R, Driss M, Ayadi A, Radouani F, Fakhkhari M, Khyatti M, Abdelhak S, Sadki K, Boubaker MS, Rebai A, Cherif B.   +23 more
europepmc   +1 more source

Development of a multi-institutional dataset to validate a novel inflammatory breast cancer diagnostic score. [PDF]

J Natl Cancer Inst
Lynce F, Niman SM, Kai M, Ryan S, Troll E, Li L, Miller KD, Jagsi R, Mason G, Overmoyer BA, Le-Petross HTC, Nakhlis F, Krishnamurthy S, Harrison BT, Sun SX, Yeh ED, Bellon JR, Warren LE, Stauder MC, Regan MM, Woodward WA.   +20 more
europepmc   +1 more source

Integrative analysis of bulk and single-cell transcriptomics identifies factors related to immunosuppressive microenvironment to predict unfavorable prognosis in inflammatory breast cancer. [PDF]

Front Immunol
Feng K, Li X, Li X, Liu J, Zhang R, Chen H, Zhang Y, He J, Zhang H.   +8 more
europepmc   +1 more source

Comparative outcomes of operable non-inflammatory and non-metastatic inflammatory breast cancer in Morocco: a retrospective cohort study. [PDF]

Front Oncol
Ismaili N, Guessous F, El Majjaoui S.
europepmc   +1 more source

Neoadjuvant therapy with eribulin, doxorubicin and cyclophosphamide for patients with HER2-negative inflammatory breast cancer: a phase II study. [PDF]

Breast Cancer Res
Fanucci K, Yeh ED, Shi R, Qin L, Bay CP, DiLullo M, Patel A, Moore M, Herbert ZT, Harrison BT, Nakhlis F, Bellon J, Warren L, Guerriero JL, Tolaney SM, Regan M, Overmoyer B, Van Laere S, Lynce F.   +18 more
europepmc   +1 more source

Clinicopathological and molecular characterization of inflammatory breast cancer, the prospective INFLAME registry study. [PDF]

NPJ Breast Cancer
van Geel JJL, Jongbloed EM, Moustaquim J, van der Schoor G, van Leeuwen-Stok AE, Smid M, van Deurzen CHM, Wilting SM, Wesseling J, Sonke GS, Martens JWM, Schröder CP.   +11 more
europepmc   +1 more source

Pharmacological inhibition of NMDA receptors reduces migration and viability in triple-negative inflammatory breast cancer cell lines. [PDF]

Discov Oncol
Mendez-Santacruz LL, Bittman-Soto XS, Molina-Nieves A, Maldonado-Vlaar CS, Peterson-Peguero E.   +4 more
europepmc   +1 more source